PharmaCorp Closes Two Previously Announced Acquisitions and Provides Acquisition Pipeline Update

PHARMACORP RX INC. announced today that, further to its August 18, 2026, news release, it has completed the acquisition of a 100 per cent interest in a PharmaChoice Canada-bannered pharmacy located in Western Canada, pursuant to the previously disclosed share purchase agreement dated August 10.

The Pharmacy Acquisition increases PharmaCorp’s overall store count to 17.

The aggregate purchase price for the Pharmacy Acquisition was $1,300,000, subject to customary post-closing adjustments, and was funded using the Corporation’s existing cash resources. The pharmacy was acquired from an arm’s length vendor group, and no finder’s fees were payable in connection with the Pharmacy Acquisition. The pharmacy will continue to be operated by its existing managing pharmacist during the transition period, supporting continuity and integration into the PharmaCorp

File acquisition and credit facility

The Corporation also announced that, further to the same August 18, 2026, news release, on September 11, 2026 it completed the acquisition of the prescription files, patient records and related operational data of an I.D.A.-bannered pharmacy located in Western Canada, pursuant to the previously disclosed asset purchase agreement dated August 7, 2026. The aggregate purchase price for the File Acquisition was $475,000, subject to customary post-closing adjustments, and was funded using the Corporation’s existing cash resources. The acquired files have been transferred to an existing PharmaCorp PharmaChoice Canada-bannered pharmacy located nearby and are being serviced from that location, consolidating patient volume into a pharmacy the Corporation already operates. The File Acquisition was an asset purchase and did not add a location to the Corporation’s operating network. The files were acquired from an arm’s length vendor, and no finder’s fees were payable in connection with the File

“We like opportunities to add prescription volume and cash flow to an existing pharmacy without the capital expense of adding another storefront,” said Alan Simpson, Executive Chairman of PharmaCorp. “We’ll continue to focus on our pharmacy acquisition strategy while also monitoring and evaluating prescription tuck-in opportunities when they arise. The expansion of our acquisition facility with CIBC from $17.5 million to $27.5 million provides additional capacity to fund future acquisitions.”

The Corporation also announced that, further to its news release dated August 13, 2025, it has exercised the previously announced $10,000,000 accordion feature under its acquisition term facility with Canadian Imperial Bank of Commerce. Pursuant to an amendment dated September 30, 2026 to the credit agreement between the Corporation and CIBC dated August 12, 2025, the credit limit of the acquisition term facility has been increased from $17,500,000 to $27,500,000. Amounts available under the facility may be used to finance acquisitions of pharmacy businesses, including the assets or shares of a pharmacy business, and acquisitions of real property in Canada for the purpose of operating a pharmacy business, on the terms and conditions set out in the credit

Acquisition pipeline update

The Corporation has executed a non-binding letter of intent dated September 11, 2026 for the proposed acquisition of three PharmaChoice Canada-bannered pharmacies located in Atlantic

The Corporation is no longer pursuing the proposed acquisitions contemplated by the non-binding letters of intent dated March 23, 2026 and June 23, 2026. Following completion of the Acquisitions and those decisions, two non-binding letters of intent remain outstanding. The proposed acquisitions contemplated by the Outstanding LOIs are non-binding and remain subject to the completion of satisfactory due diligence and the negotiation and execution of definitive purchase agreements. There can be no assurance that any of the Proposed LOI Acquisitions will be completed as proposed, or at all. No finder’s fees are payable in respect of the Proposed LOI Acquisitions. Each of the Proposed LOI Acquisitions is with an arm’s length

PharmaCorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. Through a combination of capital, strategic support and operational expertise, PharmaCorp is building a national network of community pharmacies under the PharmaChoice Canada

PharmaCorp currently operates 17 PharmaChoice Canada-bannered pharmacies and intends to continue acquiring both PharmaChoice Canada-bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform in accordance with its strategic alliance with PharmaChoice Canada, where applicable. PharmaCorp shares trade on the TSX Venture Exchange under the symbol